Table Of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
Scope and Methodolgy
Introduction
Current Stem Cell Therapies
Developmental Stem Cell Therapies
Issues In Stem Cell Research
Stem Cell Forecasts
CHAPTER TWO: INTRODUCTION
The Promise of Stem Cells In Medical Treatment
Types of Stem Cells
Embryonic Stem Cells
Adult Stem Cells
Cord Blood Stem Cells
Stem Cell Harvesting
Embryonic Stem Cells
Therapeutic Cloning
Unfertilized Eggs
Adult Stem Cells
Leukapheresis
Peripheral Blood
Cord Blood Stem Cells
Transplantation Approaches
Autologous Transplantation
Allogenic Transplantation
Transplantation Procedures
Cancerous Stem Cells
Other Harmful Stem Cells
Stem Cells in Drug Development
Stem Cell Therapeutics
Stem Cells Targeting Drugs
Stem Cell Generated Organs
CHAPTER THREE: CURRENT STEM CELL THERAPIES
Cancer
Leukemia
Gene Therapy
Multiple Myeloma
Non-Hodgkin’s Lymphoma
Non Cancerous Diseases
Aplastic anemia
Immunodeficiency
Lupus
Sickle Cell Disease
Other Conditions
CHAPTER FOUR: DEVELOPMENTAL STEM CELL THERAPIES
Alzheimer’s Disease
Arthritis
Bladder Disease
Burns
Cancer
Cardiovascular Conditions
Critical Limb Ischemia
Diabestes
Esophagal Disease
Incontinence
Infertility
Intestinal Disease
Liver Failure
Lung Disease
Multiple Sclerosis
Orthopedics
Osteoporosis
Parkinson’s Disease
Sickle Cell Disease
Tooth Disease
Wrinkles/Aging Skin
CHAPTER FIVE: STEM CELL FORECASTS
Best Case
Stem Cell Therapeutics
Umbilical Cord Blood Banking
Fees Related to Drug Development
Most Likely Case
Stem Cell Therapeutics
Umbilical Cord Blood Banking
Fees Related to Drug Development
Worst Case
Stem Cell Therapeutics
Umbilical Cord Blood Banking
Fees Related to Drug Development
CHAPTER SIX: ISSUES IN STEM CELL RESEARCH
Ethical Questions
U.S. - State and Federal Initiatives
Research Funding
Federal Funding
State Funding
Cord Blood Initiatives
International Initiatives
Stem Cell Patents
Other Healthcare Regulations
LIST OF EXHIBITS CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1 Total Market for Stem Cell Technologies in $ Millions, 2010 - 2020
Table 1-2 Stem Cell Therapeutics Market in $ Millions, 2010 - 2020
Table 1-3 Total Market for Cord Blood Banking Fees in $ Millions, 2010 - 2020
Table 1-4 Total Market for Stem Cell Drug Development Technologies in $ Millions, 2010 - 2020
Figure 1-1 Total Market for Stem Cells - Most Likely Case in $ Millions, 2010 - 2020
CHAPTER TWO: INTRODUCTION
Table 2-1 Established and Emerging Artificial Organ Products by Market Segment, 2010
CHAPTER THREE: CURRENT STEM CELL THERAPIES
Table 3-1 Types of Leukemia, 2011
CHAPTER FOUR: DEVELOPMENTAL STEM CELL THERAPIES
Table 4-1 Global Disease Populations Addressed by Potential Stem Cell Therapies, 2011
Table 4-2 Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2010 and 2020
Table 4-3 Estimated and Projected World Cancer Mortality by Selected Types of Cancer, 2010 and 2020
Table 4-4 Features and Types of Urinary Incontinence, 2011
Table 4-5 Types and Causes of Male Infertility, 2011
Table 4-6 Common Diseases of the Lungs, 2011
CHAPTER FIVE: STEM CELL FORECASTS
Table 5-1 Persons Affected by Key Stem Cell Therapeutic Targets in Millions, 2011
Table 5-2 Best Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2010 - 2020
Table 5-3 Best Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2010 - 2020
Table 5-4 131 Best Case: Cord Blood Banking Revenues in $ Millions, 2007 - 2020
Table 5-5 Best Case: Stem Cell-Based Drug Development Technology Fees, 2010 - 2020
Table 5-6 Best Case: Stem Cell-Based Drug Development Technology Fees in $ Millions, 2010 - 2020
Table 5-7 Most Likely Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2010 - 2020
Table 5-8 Most Likely Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2010 - 2020
Table 5-9 Most Likely Case: Cord Blood Banking Revenues in $ Millions, 2010 - 2020
Table 5-10 Most Likely Case: Stem Cell-Based Drug Development Technology Fees in Millions, 2010 - 2020
Table 5-11 Most Likely Case: Stem Cell-Based Drug Development Technology Fees in $ Millions, 2010 - 2020
Table 5-12 Worst Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2010 - 2020
Table 5-13 Worst Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2010 - 2020
Table 5-14 Worst Case: Cord Blood Banking Revenues in $ Millions, 2010-2020
Table 5-15 Worst Case: Stem Cell-Based Drug Development Technology Fees in Millions, 2010-2020
Table 5-16 Worst Case: Stem Cell-Based Drug Development Technology Fees in $ Millions 2010-2020
CHAPTER SIX: ISSUES IN STEM CELL RESEARCH
Table 6-1 NIH Funding for Stem Cell Research, 2002 - 2010 in $ Million
Table 6-2 U.S. State Embryonic & Fetal Research Laws
Table 6-3 Positions on Human ES Cell Research by Country, 2011
Table 6-4 EU Laws on hESC Research by Country